APA (7th ed.) Citation

Weinberg, B., Renouf, D., Lim, H., Heining, C., Schlenk, R., Jones, M., . . . Laskin, J. (2019). P-291 - NRG1-fusion positive gastrointestinal tumours: Afatinib as a novel potential treatment option. Annals of Oncology, 30, iv80. https://doi.org/10.1093/annonc/mdz155.290

Chicago Style (17th ed.) Citation

Weinberg, B., et al. "P-291 - NRG1-fusion Positive Gastrointestinal Tumours: Afatinib as a Novel Potential Treatment Option." Annals of Oncology 30 (2019): iv80. https://doi.org/10.1093/annonc/mdz155.290.

MLA (9th ed.) Citation

Weinberg, B., et al. "P-291 - NRG1-fusion Positive Gastrointestinal Tumours: Afatinib as a Novel Potential Treatment Option." Annals of Oncology, vol. 30, 2019, p. iv80, https://doi.org/10.1093/annonc/mdz155.290.